The city of Harrisburg, Pennsylvania, currently has 1 active clinical trials seeking participants for Crohn's Disease research studies.
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Recruiting
This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up to 168 weeks, with a treatment period of up to 158 weeks including an open-label (OL) long-term extension (LTE) period of up to 104 weeks for eligible participants
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/05/2025
Locations: Jackson Siegelbaum Gastroenterology - East Shore - Site Number: 8400009, Harrisburg, Pennsylvania
Conditions: Crohn's Disease